Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes.
Authors
Dylan Cooper
Northwell Health Cancer Institute/Monter Cancer Center, New Hyde Park, NY;
Dylan Cooper , Baho Sidiqi , Ruwan Parakrama , Lyudmyla Demyan , Shamsher Pasha , Danielle Pinto , Tiffany Zavadsky , Xianghui Zou , Sunita Patruni , Adrianna Kapusta , Oliver Standring , Jason Nosrati , Leila T Tchelebi , Matthew John Weiss , Joseph M. Herman , Daniel King
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 695)
DOI
10.1200/JCO.2023.41.4_suppl.695
Abstract #
695
Poster Bd #
K2
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Neoadjuvant therapy outcomes in nonmetastatic pancreatic cancer.
First Author: Jeanette Muniz Kovtun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Lymphopenia and spleen dose for patients with inoperable pancreatic cancer receiving ablative 5-fraction radiation therapy.
First Author: Michael David Chuong
Poster
2019 Gastrointestinal Cancers Symposium
Dynamical changes of treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice.
First Author: Kazuki Nagai
Poster
2015 Gastrointestinal Cancers Symposium
Role of neoadjuvant treatment regimens for locally advanced pancreatic cancer.
First Author: Mohammad Alfayez